Financhill
Sell
26

STRYF Quote, Financials, Valuation and Earnings

Last price:
$5.17
Seasonality move :
1.27%
Day range:
$5.17 - $5.17
52-week range:
$2.60 - $5.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.13x
P/B ratio:
3.18x
Volume:
--
Avg. volume:
--
1-year change:
98.85%
Market cap:
$398.8M
Revenue:
$329.6M
EPS (TTM):
-$0.81
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $195.1M $244.3M $306.2M $319.1M $329.6M
Revenue Growth (YoY) 16.01% 25.2% 25.33% 4.21% 3.29%
 
Cost of Revenues $121.2M $150.7M $187.8M $198.1M $211.8M
Gross Profit $74M $93.6M $118.4M $121M $117.8M
Gross Profit Margin 37.91% 38.3% 38.66% 37.91% 35.75%
 
R&D Expenses -- $16.5M $24.2M $32.2M $28.6M
Selling, General & Admin $65.2M $98M $99.2M $86.2M $71.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $112.7M $112.9M $160.2M $162.2M $189.4M
Operating Income -$38.7M -$19.3M -$41.8M -$41.3M -$71.5M
 
Net Interest Expenses $622.3K $1.3M -- $3.7M $5.2M
EBT. Incl. Unusual Items -$40.2M -$20.9M -$41.2M -$39.4M -$76.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$7.1M -$321.7K $2.4M -$339.2K $571.7K
Net Income to Company -$40.2M -$20.9M -$41.2M -$39.4M -$76.3M
 
Minority Interest in Earnings -- -- -$993.3K -$267.9K -$534.9K
Net Income to Common Excl Extra Items -$33.1M -$20.6M -$44.6M -$39.3M -$77.4M
 
Basic EPS (Cont. Ops) -$0.59 -$0.34 -$0.66 -$0.57 -$1.00
Diluted EPS (Cont. Ops) -$0.59 -$0.34 -$0.66 -$0.57 -$1.00
Weighted Average Basic Share $56.1M $61.4M $67.2M $69.5M $77.1M
Weighted Average Diluted Share $56.1M $61.4M $67.2M $69.5M $77.1M
 
EBITDA -$31.8M -$8.6M -$18.8M -$7.1M -$18.9M
EBIT -$38.9M -$19.6M -$40.1M -$35.4M -$70.1M
 
Revenue (Reported) $195.1M $244.3M $306.2M $319.1M $329.6M
Operating Income (Reported) -$38.7M -$19.3M -$41.8M -$41.3M -$71.5M
Operating Income (Adjusted) -$38.9M -$19.6M -$40.1M -$35.4M -$70.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $68.8M $78.8M $76.9M $83M $91.9M
Revenue Growth (YoY) 34.14% 14.64% -2.51% 8.05% 10.71%
 
Cost of Revenues $35.5M $46.4M $47.1M $48.9M $50.1M
Gross Profit $33.3M $32.4M $29.7M $34.1M $41.8M
Gross Profit Margin 48.4% 41.11% 38.71% 41.06% 45.48%
 
R&D Expenses -- $5.4M $7.9M $5.7M $5.2M
Selling, General & Admin $19.4M $32.5M $24.6M $27.9M $27.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $35.8M $37.5M $32.2M $33.1M $33.6M
Operating Income -$2.5M -$5.1M -$2.5M $947.3K $8.2M
 
Net Interest Expenses $272.2K $608.7K -- $1.3M $2.5M
EBT. Incl. Unusual Items -$2.8M -$5.8M $407.3K $62.7K $5.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$77.9K -$146K $641.6K $245.1K $612K
Net Income to Company -$3.9M -$5.2M $2.4M $266.1K $6M
 
Minority Interest in Earnings -- -$495.2K -$46.8K -$251K -$361K
Net Income to Common Excl Extra Items -$2.7M -$6.1M -$281.2K -$433.4K $4.9M
 
Basic EPS (Cont. Ops) -$0.04 -$0.09 -$0.00 -$0.01 $0.06
Diluted EPS (Cont. Ops) -$0.04 -$0.09 -$0.00 -$0.01 $0.06
Weighted Average Basic Share $62.3M $68.6M $73.7M $77.9M $76.7M
Weighted Average Diluted Share $62.3M $68.6M $73.7M $77.9M $76.7M
 
EBITDA $793.3K -$5.1M -$2.5M $947.3K $8.2M
EBIT -$2.5M -$5.1M -$2.5M $947.3K $8.2M
 
Revenue (Reported) $68.8M $78.8M $76.9M $83M $91.9M
Operating Income (Reported) -$2.5M -$5.1M -$2.5M $947.3K $8.2M
Operating Income (Adjusted) -$2.5M -$5.1M -$2.5M $947.3K $8.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $238.2M $287M $320.7M $321.6M $353.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $129.4M $194.3M $198.4M $195.3M $215.4M
Gross Profit $108.9M $92.7M $122.3M $126.3M $138.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $33.7M $25.2M $28.7M
Selling, General & Admin $73.7M $142.5M $105.8M $72.7M $71.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $133.7M $124.9M $173.3M $139.7M $192.2M
Operating Income -$24.8M -$32.2M -$51M -$13.4M -$53.9M
 
Net Interest Expenses $471.1K $1.2M -- $10M $6.5M
EBT. Incl. Unusual Items -$26.2M -$33.5M -$44.1M -$17.5M -$61M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$5.4M $3.2M $1.7M $1.2M $590K
Net Income to Company -$27.9M -$32M -$41.5M -$19.1M -$61.3M
 
Minority Interest in Earnings -- -$685K -$504.5K -$511.9K -$897.5K
Net Income to Common Excl Extra Items -$20.8M -$37.4M -$46.3M -$19.1M -$62.5M
 
Basic EPS (Cont. Ops) -$0.35 -$0.57 -$0.68 -$0.25 -$0.81
Diluted EPS (Cont. Ops) -$0.35 -$0.57 -$0.68 -$0.25 -$0.81
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$15.5M -$32.4M -$49.3M -$7.8M -$52.4M
EBIT -$25M -$32.4M -$49.3M -$7.8M -$52.4M
 
Revenue (Reported) $238.2M $287M $320.7M $321.6M $353.7M
Operating Income (Reported) -$24.8M -$32.2M -$51M -$13.4M -$53.9M
Operating Income (Adjusted) -$25M -$32.4M -$49.3M -$7.8M -$52.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $179.4M $221.8M $236.9M $240.4M $264.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $93.6M $135.6M $146.5M $144.3M $147.8M
Gross Profit $85.8M $86.2M $90.4M $96.1M $116.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $16M $25.6M $18.5M $18.5M
Selling, General & Admin $54.9M $98M $103.4M $86.1M $86.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $99.8M $113.3M $126.7M $103.1M $106.2M
Operating Income -$14M -$27.1M -$36.3M -$7M $10.6M
 
Net Interest Expenses $1.6M $1.3M $688.4K $2.9M $4M
EBT. Incl. Unusual Items -$15.3M -$28.1M -$31.1M -$7.8M $7.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$2.9M $328.4K -$329.7K $1.2M $1.2M
Net Income to Company -$16.4M -$27.5M -$27.8M -$7.6M $7.4M
 
Minority Interest in Earnings -- -$685K -$206.7K -$445.8K -$811.2K
Net Income to Common Excl Extra Items -$12.4M -$29.1M -$30.9M -$9.5M $5.3M
 
Basic EPS (Cont. Ops) -$0.20 -$0.43 -$0.45 -$0.12 $0.07
Diluted EPS (Cont. Ops) -$0.20 -$0.43 -$0.45 -$0.12 $0.07
Weighted Average Basic Share $183.1M $200.9M $209.8M $232.8M $231.1M
Weighted Average Diluted Share $183.1M $200.9M $209.8M $232.8M $231.1M
 
EBITDA -$6.4M -$27.1M -$36.3M -$7M $10.6M
EBIT -$14M -$27.1M -$36.3M -$7M $10.6M
 
Revenue (Reported) $179.4M $221.8M $236.9M $240.4M $264.6M
Operating Income (Reported) -$14M -$27.1M -$36.3M -$7M $10.6M
Operating Income (Adjusted) -$14M -$27.1M -$36.3M -$7M $10.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $34.4M $44.2M $100.1M $74.5M $43.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $19M $27.4M $34.5M $21.4M $19.3M
Inventory $7.7M $6.5M $7.3M $9.8M $5.9M
Prepaid Expenses $17.6M $29.9M $30.8M $27.9M $26.1M
Other Current Assets -- -- $110 -- --
Total Current Assets $89M $124.7M $192.4M $142.1M $105.3M
 
Property Plant And Equipment $17M $20.3M $17.6M $13.6M $10.1M
Long-Term Investments -- -- -- -- --
Goodwill $17.2M $37.3M $46.2M $121.5M $76.3M
Other Intangibles $11.7M $43.6M $71.3M $130.1M $112.7M
Other Long-Term Assets -- $442.4K $110 -- -$200
Total Assets $138.4M $230.8M $332.6M $415.2M $312M
 
Accounts Payable $12.5M $18.1M $18.9M $11.7M $27.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $3.1M $4.1M $4M $3.4M $4.1M
Other Current Liabilities $5M $6.8M $8.9M $4.7M $5.3M
Total Current Liabilities $80.3M $85.6M $93M $130.9M $168.2M
 
Long-Term Debt $21M -- -- $57.4M --
Capital Leases -- -- -- -- --
Total Liabilities $123.9M $114.1M $121.4M $210.6M $185.5M
 
Common Stock $3M $3.8M $3.8M $3.7M $3.8M
Other Common Equity Adj -- -- -- -- --
Common Equity $14.4M $116.7M $203M $197.8M $120M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $8.2M $6.7M $6.5M
Total Equity $14.4M $116.7M $211.2M $204.5M $126.5M
 
Total Liabilities and Equity $138.4M $230.8M $332.6M $415.2M $312M
Cash and Short Terms $34.4M $44.2M $100.1M $74.5M $43.3M
Total Debt $42.8M $258.4K -- $105.4M $74.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $64.9M $136.5M $41.1M $49.5M $44.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $54.6M $74.9M $57.8M $58.2M $20.9M
Inventory $8.6M $7.2M $10.9M $8.2M $5.7M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $128M $218.6M $109.8M $115.8M $102.5M
 
Property Plant And Equipment $2.7M $2.7M $13.1M $10.7M $9.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $207.5M $345.3M $378.8M $376.5M $300.7M
 
Accounts Payable -- -- -- -- $22.7M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $129.6M
Total Current Liabilities $62.2M $83.1M $119.5M $91.8M $152.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $67.5M $90.9M $201.7M $178.6M $168.8M
 
Common Stock $3.5M $3.9M -- -- $3.8M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $8M -- -- $6.6M
Total Equity $139.9M $254.3M $177.2M $198M $131.9M
 
Total Liabilities and Equity $207.5M $345.3M $378.8M $376.5M $300.7M
Cash and Short Terms $64.9M $136.5M $41.1M $49.5M $44.4M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$40.2M -$20.9M -$41.2M -$39.4M -$76.3M
Depreciation & Amoritzation $7.1M $11M $21.3M $28.3M $31M
Stock-Based Compensation -- $2.8M -- -- --
Change in Accounts Receivable -$4.6M -$18.1M -$17.1M $12.5M $5.7M
Change in Inventories $1.4M $2M -$583.7K -$3.3M $2.6M
Cash From Operations -$35.8M -$9.1M -$25.6M -$10M $23.5M
 
Capital Expenditures $2M $29.3M $38.3M $25.6M $17.8M
Cash Acquisitions -$3M -$11.7M -$4.9M -$88.4M -$403.8K
Cash From Investing -$4.9M -$41.2M -$43.4M -$113.8M -$18.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $20M -- -- $119.6M $28.3M
Long-Term Debt Repaid -$2.3M -$43.7M -$247.2K -$46.3M -$61.4M
Repurchase of Common Stock -- -- -- -- -$101.4K
Other Financing Activities -- $110 -- -- $90
Cash From Financing $17.7M $56.7M $132.2M $108.2M -$37.2M
 
Beginning Cash (CF) $61.7M $35.1M $42.3M $90.3M $73.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$23.1M $6.3M $63.3M -$15.6M -$32M
Ending Cash (CF) $38.7M $39.5M $105.8M $77.4M $41.2M
 
Levered Free Cash Flow -$37.8M -$38.4M -$63.8M -$35.6M $5.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$3.9M -$5.2M $2.4M $266.1K $6M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- $18.1M -$1.4M -$1.1M
Change in Inventories -- -- -$5M $475.1K -$67.8K
Cash From Operations -$235.4K -$7.3M $8.1M $11M $18.8M
 
Capital Expenditures -- -- -- $3.1M $3.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$15.9M -$6M $914.7K -$4.1M -$4.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -$28.6M --
Long-Term Debt Repaid -- -- -- $24.2M -$261.4K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$656.1K -$959K
Cash From Financing $5.2M -$5M -$5.7M -$5M -$1.2M
 
Beginning Cash (CF) $73.5M $149.7M $45.8M $50.6M $29.5M
Foreign Exchange Rate Adjustment -$339.1K $42.7K $758.6K -$494.8K -$614.7K
Additions / Reductions -$10.9M -$18.4M $3.3M $2M $13.2M
Ending Cash (CF) $65.7M $130.2M $43.6M $50.1M $43.2M
 
Levered Free Cash Flow -$235.4K -$7.3M $8.1M $7.9M $15.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$27.9M -$32M -$41.5M -$19.1M -$61.3M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$447K $3.5M
Change in Inventories -- -- -- $3M $1.4M
Cash From Operations -$17.6M -$9.8M -$24.5M $14.2M $33.1M
 
Capital Expenditures -- -- -- $11M $16.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$29.4M -$46.8M -$112.7M -$24M -$16.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $82.1M $125.5M $68.4M $15M -$23.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $35M $68.9M -$68.8M $5.3M -$7.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$17.6M -$9.8M -$24.5M $14.2M $16.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$16.4M -$27.5M -$27.8M -$7.6M $7.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- $18.1M $5.1M $3M
Change in Inventories -- -- -$5M $1.3M $37.3K
Cash From Operations -$8.1M -$8.8M -$7.7M $16.5M $26.2M
 
Capital Expenditures -- -- -- $11M $10M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$28.5M -$34.1M -$103.4M -$13.6M -$12.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$23.3M -$9.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$2.8M -$3.3M
Cash From Financing $61.9M $130.8M $67M -$26.2M -$12.9M
 
Beginning Cash (CF) $227M $360.9M $191.1M $176.9M $105.5M
Foreign Exchange Rate Adjustment -$925.9K $375.5K $1.3M $1.4M $78.6K
Additions / Reductions $25.3M $88M -$44.1M -$23.2M $1.1M
Ending Cash (CF) $254.7M $447.9M $137.5M $152.5M $106.6M
 
Levered Free Cash Flow -$8.1M -$8.8M -$7.7M $5.5M $16.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock